Answers are grounded in this paper and cite their sources.
The mRNA-1273 vaccine continued to be efficacious in preventing Covid-19 illness and severe disease at more than 5 months, with an acceptable safety profile, and protection against asymptomatic infection was observed. (Funded by the Biomedical Advanced Research and Development Authority and the National Institute of Allergy and Infectious Diseases; COVE ClinicalTrials.gov number, NCT04470427.).
No takes yet. Share an insight, caveat, or question.
Sahly et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: